Literature DB >> 2047763

IgG subclasses in bronchoalveolar lavage fluid from patients with asthma.

T A Out1, E A van de Graaf, N J van den Berg, H M Jansen.   

Abstract

We have measured Immunoglobulin G (IgG) subclasses in serum and bronchoalveolar lavage fluid (BALF) from 12 non-smoking patients with stable asthma and 9 non-smoking healthy volunteers to obtain information on their possible role in local immunological reactions. The quotients (concentration of IgG subclass in BALF)/(concentration of IgG subclass in serum) were calculated. In controls QIgG3 were lower than QIgG1, QIgG2 and QIgG4. The IgG subclasses in BALF and epithelial lining fluid (ELF) from patients with asthma were significantly higher than in controls, mainly due to increased leakage from the blood. Again QIgG3 were lower than Q of other subclasses. In the analysis of local production of IgG, albumin or ceruloplasmin was used as reference protein. Several patients showed a local production or a preferential accumulation of one or more IgG subclasses. We conclude that in healthy persons the IgG subclasses in ELF originate from the systemic circulation by passive permeation. In patients with asthma, the permeability of the respiratory membrane may be increased resulting in increased concentrations of subclasses in lung-lining fluid. In some patients with asthma, an additional local production of IgG subclasses occurs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2047763     DOI: 10.1111/j.1365-3083.1991.tb02546.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  9 in total

1.  Immunoglobulin isotypes in childhood asthma.

Authors:  F I Najam; A S Giasuddin; A H Shembesh
Journal:  Indian J Pediatr       Date:  1999 May-Jun       Impact factor: 1.967

2.  IL-33-dependent induction of allergic lung inflammation by FcγRIII signaling.

Authors:  Melissa Y Tjota; Jesse W Williams; Tiffany Lu; Bryan S Clay; Tiara Byrd; Cara L Hrusch; Donna C Decker; Claudia Alves de Araujo; Paul J Bryce; Anne I Sperling
Journal:  J Clin Invest       Date:  2013-04-15       Impact factor: 14.808

3.  Children with chronic renal failure have reduced numbers of memory B cells.

Authors:  A H M Bouts; J C Davin; R T Krediet; L A H Monnens; J Nauta; C H Schröder; R A W van Lier; T A Out
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

4.  Allergen-specific IgG1 and IgG3 through Fc gamma RII induce eosinophil degranulation.

Authors:  M Kaneko; M C Swanson; G J Gleich; H Kita
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

5.  Complement activation by polyclonal immunoglobulin G1 and G2 antibodies against Staphylococcus aureus, Haemophilus influenzae type b, and tetanus toxoid.

Authors:  R G Bredius; P C Driedijk; M F Schouten; R S Weening; T A Out
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

6.  Lyn but not Fyn kinase controls IgG-mediated systemic anaphylaxis.

Authors:  Yves T Falanga; Natalia S Chaimowitz; Nicolas Charles; Fred D Finkelman; Nicholas A Pullen; Suzanne Barbour; Kevin Dholaria; Travis Faber; Motunrayo Kolawole; Bernice Huang; Sandra Odom; Juan Rivera; Jason Carlyon; Daniel H Conrad; Sarah Spiegel; Carole A Oskeritzian; John J Ryan
Journal:  J Immunol       Date:  2012-03-26       Impact factor: 5.426

7.  Contributions of direct versus indirect mechanisms for regulatory dendritic cell suppression of asthmatic allergen-specific IgG1 antibody responses.

Authors:  Yanna Ma; Wojciech Dawicki; Xiaobei Zhang; John R Gordon
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

8.  The contribution of allergen-specific IgG to the development of th2-mediated airway inflammation.

Authors:  Jesse W Williams; Melissa Y Tjota; Anne I Sperling
Journal:  J Allergy (Cairo)       Date:  2012-10-21

9.  Signaling through Fc gamma RIII is required for optimal T helper type (Th)2 responses and Th2-mediated airway inflammation.

Authors:  Hozefa S Bandukwala; Bryan S Clay; Jiankun Tong; Purvi D Mody; Judy L Cannon; Rebecca A Shilling; J Sjef Verbeek; Joel V Weinstock; Julian Solway; Anne I Sperling
Journal:  J Exp Med       Date:  2007-07-30       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.